• 1
    Lenart BA, Lorich DG, Lane JM 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358: 13041306.
  • 2
    Kwek EBK, Koh JSB, Howe TS 2008 More on atypical fractures of the femoral diaphysis. N Engl J Med 359: 316318.
  • 3
    Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY 2005 Severely suppressed bone turnover: A potential complication of alendronate therapy. J Clin Endocrinol Metab 90: 12941301.
  • 4
    Armamento-Villareal R, Napoli N, Panwar V, Novack D 2006 Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis. N Engl J Med 355: 20482050.
  • 5
    Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS 2007 Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br 89: 349353.
  • 6
    Lee P, van der Wall H, Seibel MJ 2007 Looking beyond low bone mineral density: Multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy. J Endocrinol Invest 30: 590597.
  • 7
    Sayed-Noor AS, Sjödén GO 2008 Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy–a case report. Acta Orthop 79: 565567.
  • 8
    Visekruna M, Wilson D, McKiernan FE 2008 Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 93: 29482952.
  • 9
    Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorigch DG 2008 Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22: 346350.
  • 10
    Scheider JP 2006 Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate. Geriatrics 61: 3133.
  • 11
    Aspenberg P 2008 Bisphosphonate-induced fractures: Nature strikes back ? Acta Orthop 79: 459460.
  • 12
    Whyte MP, Teitelbaum SL, Murphy WA, Bergfeld MA, Avioli LV 1979 Adult hypophosphatasia: Clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine 58: 329347.
  • 13
    Whyte MP, Murphy WA, Fallon MD 1982 Adult hypophosphatasia with chondrocalcinosis and arthropathy. Am J Med 72: 631641.
  • 14
    Whyte MP 2001 Hypophosphatasia. In: ScriverCR, BeaudetAL, SlyWS, ValleD (eds.) The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill, New York, NY, USA 53135329.
  • 15
    Whyte MP 2008 Hypophosphatasia: Nature's window on alkaline phosphatase function in humans. In: BilezkikianJP, RaiszLG, MartinTJ, eds. Principles of Bone Biology, 3rd ed. Academic Press, San Diego, CA, USA 15731598.
  • 16
    Khandwala HM, Mumm S, Whyte MP 2006 Low serum alkaline phosphatase activity and pathologic fracture: Case report and brief review of hypophosphatasia diagnosed in adulthood. Endocr Pract 12: 676681.
  • 17
    Whyte MP, Mumm S, Deal C 2007 Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 92: 12031208.
  • 18
    Coe JD, Murphy WA, Whyte MP 1986 Management of femoral fractures and pseudofractures in adult hypophosphatasia. J Bone Joint Surg Am 68: 981990.
  • 19
    Whyte MP, Wenkert D, McAlister WH, Mughal Z, Freemont AJ, Whitehouse R, Baildam E, Mumm S 2008 Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia. J Bone Miner Res (in press).
  • 20
    Steinbach HL, Noetzli M 1964 Roentgen appearance of the skeleton in osteomalacia and rickets. Am J Roentgenol Radium Ther Nucl Med 91: 955972.
  • 21
    Hardy DC, Murphy WA, Siegel BA, Reid IR, Whyte MP 1989 X-linked hypophosphatemia in adults: Prevalence of skeletal radiographic and scintigraphic features. Radiology 171: 403414.
  • 22
    Pauwels F 1950 Die bedeutung der bauprinzipien des stutz — und bewegungsapparates fur die beanspruchung der Röhrenknochen. Z Anat EntwicklGesch 114: 129166.
  • 23
    Drake MT, Clarke BL, Khosla S 2008 Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin Proc 83: 10321045.